Bio-Rad Laboratories (BIO) Other Non-Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Other Non-Current Liabilities data on file, last reported at $198.4 million in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 14.62% year-over-year to $198.4 million in Q1 2026; TTM through Mar 2026 was $198.4 million, a 14.62% increase from a year earlier, with the FY2025 full-year figure at $199.1 million, up 12.36% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $198.4 million, roughly flat from $199.1 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for BIO reached as high as $209.6 million in Q2 2025 and fell as low as $173.1 million in Q1 2025.
• Historically, Other Non-Current Liabilities has averaged $193.5 million across 5 years, with a median of $195.9 million in 2022.
• Across the five-year window, Other Non-Current Liabilities decreased 21.31% in 2022 and climbed 14.62% in 2026, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $195.9 million in 2022, then fell by 0.47% to $195.0 million in 2023, then dropped by 9.13% to $177.2 million in 2024, then rose by 12.36% to $199.1 million in 2025, then decreased by 0.35% to $198.4 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $198.4 million in Q1 2026, $199.1 million in Q4 2025, and $207.5 million in Q3 2025.